These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 10644785)

  • 1. Tardive and idiopathic oromandibular dystonia: a clinical comparison.
    Tan EK; Jankovic J
    J Neurol Neurosurg Psychiatry; 2000 Feb; 68(2):186-90. PubMed ID: 10644785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peripherally induced oromandibular dystonia.
    Sankhla C; Lai EC; Jankovic J
    J Neurol Neurosurg Psychiatry; 1998 Nov; 65(5):722-8. PubMed ID: 9810945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and treatment of cervical and oromandibular dystonia in acutely brain-injured patients.
    Lo SE; Rosengart AJ; Novakovic RL; Kang UJ; Shah DN; Khan MA; Dalvi A; Goldenberg FD; Macdonald RL; Frank JI
    Neurocrit Care; 2005; 3(2):139-45. PubMed ID: 16174883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of jaw-closing and jaw-opening idiopathic oromandibular dystonia.
    Singer C; Papapetropoulos S
    Parkinsonism Relat Disord; 2006 Mar; 12(2):115-8. PubMed ID: 16271495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Botulinum toxin A in patients with oromandibular dystonia: long-term follow-up.
    Tan EK; Jankovic J
    Neurology; 1999 Dec; 53(9):2102-7. PubMed ID: 10599789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical comparison of tardive and idiopathic cervical dystonia.
    Molho ES; Feustel PJ; Factor SA
    Mov Disord; 1998 May; 13(3):486-9. PubMed ID: 9613742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Botulinum toxin type B in the management of dystonia non-responsive to botulinum toxin type A].
    Cardoso F
    Arq Neuropsiquiatr; 2003 Sep; 61(3A):607-10. PubMed ID: 14513166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of intractable tardive lingual dyskinesia with botulinum toxin.
    Beckmann YY; Seçil Y; Saka S; Kuserli A; Çiftçi Y
    J Clin Psychopharmacol; 2011 Apr; 31(2):250-1. PubMed ID: 21364341
    [No Abstract]   [Full Text] [Related]  

  • 9. Efficacy of aripiprazole in sulpiride-induced tardive oromandibular dystonia.
    Imai N; Ikawa M
    Intern Med; 2011; 50(6):635-7. PubMed ID: 21422693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic review of botulinum toxin treatment for oromandibular dystonia.
    Comella CL
    Toxicon; 2018 Jun; 147():96-99. PubMed ID: 29453996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact on quality of life of botulinum toxin treatments for spasmodic dysphonia and oromandibular dystonia.
    Bhattacharyya N; Tarsy D
    Arch Otolaryngol Head Neck Surg; 2001 Apr; 127(4):389-92. PubMed ID: 11296046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oromandibular dystonia, mental distress and oro-facial dysfunction-A follow-up 8-10 years after start of treatment with botulinum toxin.
    Bakke M; Baram S; Dalager T; Biernat HB; Møller E
    J Oral Rehabil; 2019 May; 46(5):441-449. PubMed ID: 30664806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Refractory Open Jaw Oromandibular Tardive Dystonia with a Sensory Trick, Treated with Botulinum Toxin: A Case Report.
    Shalash AS; Abushouk AI; Elsherbeny MY; Elrassas H; Kamel T
    Neurol India; 2019; 67(4):1110-1111. PubMed ID: 31512647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical, Etiological, and Therapeutic Features of Jaw-opening and Jaw-closing Oromandibular Dystonias: A Decade of Experience at a Single Treatment Center.
    Gonzalez-Alegre P; Schneider RL; Hoffman H
    Tremor Other Hyperkinet Mov (N Y); 2014; 4():231. PubMed ID: 24847442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oromandibular Dystonia: Demographics and Clinical Data from 240 Patients.
    Slaim L; Cohen M; Klap P; Vidailhet M; Perrin A; Brasnu D; Ayache D; Mailly M
    J Mov Disord; 2018 May; 11(2):78-81. PubMed ID: 29860784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful treatment of tardive lingual dystonia with botulinum toxin: case report and review of the literature.
    Hennings JM; Krause E; Bötzel K; Wetter TC
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jul; 32(5):1167-71. PubMed ID: 17936461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oromandibular Dystonia: Clinical and Demographic Data from Eight-Two Patients.
    Balal M; Demirkiran M
    Tremor Other Hyperkinet Mov (N Y); 2023; 13():3. PubMed ID: 36789171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An elderly female patient with tardive oromandibular dystonia after prolonged use of the histamine analog betahistine.
    De Riu G; Sanna MP; De Riu PL
    J Clin Neurosci; 2010 Oct; 17(10):1330-1. PubMed ID: 20594853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacologic characteristics of Meige dystonia: differentiation from tardive dyskinesia.
    Stahl SM; Yesavage JA; Berger PA
    J Clin Psychiatry; 1982 Nov; 43(11):445-6. PubMed ID: 7174619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The natural history of tardive dystonia. A long-term follow-up study of 107 cases.
    Kiriakakis V; Bhatia KP; Quinn NP; Marsden CD
    Brain; 1998 Nov; 121 ( Pt 11)():2053-66. PubMed ID: 9827766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.